Comparison of T cell responses in patients with a long-term surviving renal allograft versus a long-term surviving liver allograft. It's a different world

Transplantation

Volumn 61, Issue 9, 1996, Pages 1392-1397

  Van Twuyver, E ^a   De Hoop, J ^e   Ten Berge, R J M ^b   Wilmink, J M ^b   Lems, S P M ^c   Van De Berg, A P ^c   Slooff, M J H ^c   De Waal, L P ^a,d  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d CLB   (Netherlands)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; GRAFT SURVIVAL; HUMAN; IMMUNOLOGICAL TOLERANCE; KIDNEY ALLOGRAFT; LIVER TRANSPLANTATION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

CYTOTOXICITY, IMMUNOLOGIC; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HUMANS; IMMUNITY, CELLULAR; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; T-LYMPHOCYTES; TIME FACTORS;

EID: 0029879713     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199605150-00019     Document Type: Review

References (38)

1. De Waal LP, van Twuyver E. Blood transfusion and allograft survival. Crit Rev Immunol 1991; 10: 417.
2. Lagaaij EL, Henneman IPH, Ruigrok M, et al. Effect of one HLA-DR antigen-matched and completely HLA-DR-mismatched blood transfusions on survival of heart and kidney allografts. N Engl J Med 1989; 321: 701.
3. Van Rood JJ, Claas FHJ. The influence of allogeneic cells on the human T- and B-cell repertoire. Science 1990; 248: 1388.
4. Van Twuyver E, Mooijaart RJD, ten Berge RJM, et al. Pretransplant blood transfusion revisited. N Engl J Med 1991; 325: 1210.
5. Strober S, Dhillon M, Schubert M, et al. Acquired immune tolerance to cadaveric renal allograft. N Engl J Med 1989; 321: 28.
6. Takiff H, Cook DJ, Himaya NS, Mickey MR, Terasaki PI. Dominant effect of histocompatibility on ten-year kidney transplant survival. Transplantation 1988; 45: 410.
7. Gjertson DW. Survival trends in long-term first cadaver-donor kidney transplants. In: P Terasaki, ed. Clinical Transplants 1991. Los Angeles: UCLA Tissue Typing Laboratory, 1991: 225.
8. Thorogood J, Persijn GG, Schreuder GMTh, et al. The effect of HLA-matching on kidney graft survival in separate posttransplantation time intervals. Transplantation 1990; 50: 146.
9. Opelz G, Schwarz V, Engelmann A, Back D, Wilk M, Keppel E. Long-term impact of HLA-matching on kidney graft survival in cyclosporine-treated recipients. Transplant Proc 1991; 23: 373.
10. Thorogood J, van Houwelingen JC, van Rood JJ, Zantvoort FA, Schreuder GMTh, Persijn GG. Factors contributing to the long-term kidney graft survival in Eurotransplant. Transplantation 1992; 54: 152.
11. Calne RY, Sells RA, Pena JR, et al. Induction of immunologic tolerance by porcine liver allografts. Nature 1969; 223: 472.
12. Flye MW, Duffy B, Phelan D, Ratner LE, Mohanakumar T. Protective effects of liver transplantation on a simultaneously transplanted kidney in a highly sensitized patient. Transplantation 1990; 50: 1051.
13. Goulmy E, Persijn GG, Blokland E, van Rood JJ. Cell-mediated lympholysis studies in renal allograft recipients. Transplantation 1981; 31: 210.
14. Pfeffer PF, Thorsby E, Hirschberg H. Cell-mediated cytotoxicity toward the donor in patients with well-functioning kidney grafts: possible mechanism of specially reduced cytotoxic response. Transplantation 1983; 35: 546.
15. Goulmy E, Blokland E, Persijn GG, Paul LC, Wilmink JM, van Rood JJ. HLA regulates postrenal transplant CML nonreactivity. J Immunol 1985; 135: 3082.
16. Cohen DJ, Lee HM, Mohanakumar T. Mechanisms of CML hyporesponsiveness in long-term renal allograft recipients. Hum Immunol 1985; 14: 279.
17. Wramner L, Olausson M, Soderstrom T, Lindholm L, Rydberg L, Brynger H. Evidence of donor-specific cellular suppressor activity in donor-specific cell-mediated lympholysis unresponsiveness in renal transplant patients. Transplantation 1987; 44: 390.
18. Herzog W-R, Zanker B, Irschick E, Huber C, Franz HE, Wagner H, Kabelitz D. Selective reduction of donor-specific cytotoxic T-lymphocyte precursors in patients with a well-functioning kidney allograft. Transplantation 1987; 43: 384.
19. Goulmy E, Stijnen T, Groenewoud AF, et al. Renal transplant patients monitored by the cell-mediated lympholysis assay. Transplantation 1989; 48: 559.
20. Mathew JM, Marsh JW, Susskind B, Mohanakumar TJ. Analysis of T-cell responses in liver allograft recipients. Evidence for deletion of donor-specific cytotoxic T cells in the peripheral circulation. Clin Invest 1993; 91: 900.
21. Strijbosch LWG, Does RJJM, Buurman WA. Computer-aided design and evaluation of limiting dilution experiments. Int J Biomed Comput 1988; 23: 279.
22. Dallman MJ, Wood KJ, Morris PJ. Specific cytotoxic T cells are found in the non-rejected kidneys of blood-transfused rats. J Exp Med 1987; 165: 566.
23. Dallman MJ, Shiho O, Page TH, Wood KJ, Morris PJ. Peripheral tolerance to alloantigen results from altered regulation of the interleukin-2 pathway. J Exp Med 1991; 173: 70.
24. Clerici M, Shearer GM. Differential sensitivity of human T-helper pathways by in vitro exposure to cyclosporin A. J Immunol 1990; 144: 2480.
25. Via CS, Tsokos GC, Stocks NI, Clerici M, Shearer GM. Human in vitro allogeneic responses: demonstration of three pathways of T-helper cell activity. J Immunol 1990; 144: 2524.
26. Sherwood RA, Brent L, Rayfield LS. Presentation of alloantigens by host cells. Eur J Immunol 1986; 16: 569.
27. Breur-Vriesendorp BS, Ivanyi P. Self-restricted primary histocompatibility leukocyte antigen (HLA)-specific cytotoxic T lymphocytes. Int Immunol 1993; 5: 103.
28. + T-helper cell function with clinical status in immunosuppressed kidney transplant recipients. Transplantation 1991; 52: 284.
29. Lantz O, Alard P, Ben Aribia HM, et al. Persistence of donor-specific IL-2-secreting cells and cytotoxic T-lymphocyte precursors in human kidney transplant recipients evidenced by limiting dilution analysis. J Immunol 1990; 144: 3748.
30. Starzl TE, Demetris AJ, Trucco M, et al. Systemic chimerism in human female recipients of male livers. Lancet 1992; 340: 876.
31. Starzl TE, Demetris AJ, Trucco M, et al. Chimerism after liver transplantation for type-IV glycogen storage disease and type-I Gaucher's disease. N Engl J Med 1993; 328: 745.
32. Schutt HJ, Hundrieser J, Hisanaga M, et al. Patterns of donor-type microchimerism after heart transplantation. Lancet 1994; 343: 1469.
33. Starzl TE, Demetris AJ, Trucco M, et al. Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation 1993; 55: 1272.
34. Suberbielle C, Caillat-Zucman S, Legendre C, et al. Peripheral microchimerism in long-term cadaveric kidney allograft recipients. Lancet 1994; 343: 1468.
35. Fontes P, Rao AS, Demetris AJ, et al. Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart and pancreas islet transplantation. Lancet 1994; 344: 151.
36. Demetris AJ, Murase N, Starzl TE. Dendritic cells after liver and heart allotransplantation under short-term immunosuppression. Lancet 1992; 339: 1610.
37. Ricordi C, Ildstadt S, Demetris AJ, Abou El-Ezz AY, Murase N, Starzl TE. Donor dendritic cell repopulation in recipients after rat-to-mouse bone marrow transplantation. Lancet 1992; 339: 1610.
38. Klompmaker JJ, Gouw ASH, Haagsma EB, Verwer R, Slooff MJH. Histological and biochemical effects of cyclosporine-A withdrawal from a triple drug regimen after over 2 years of treatment in liver transplant patients. J Hepatol 1995; 22: 151.